In view of the shortage of Remdesivir in Uttar Pradesh, Chief Minister Yogi Adityanath on Wednesday directed the state health department to acquire 25,000 injections of Remdesivir from Gujarat's Ahmedabad on an urgent basis.
According to the Chief Minister's Office (CMO), the officers of the Health Department left for Ahmedabad to get 25000 Remedisver injections at 10.40 am today.
Remdesivir is considered a key anti-viral drug in the fight against COVID-19.
Earlier, the Centre on Sunday prohibited exports of injection Remdesivir and Remdesivir Active Pharmaceutical Ingredients (API) till the COVID-19 situation in the country improves.
Meanwhile, the UP CM on Tuesday went into self-isolation after coming into contact with some officials who tested positive for COVID-19.
"A few officials in my office have contracted COVID-19. I had come into their contact. That is why, as a precautionary measure, I am self-isolating myself and will work virtually," the UP CM tweeted in Hindi.
Uttar Pradesh reported 18,021 new COVID-19 cases and 85 deaths on Tuesday.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)